Company Overview
- Website
- ausperbio.com
- Phone
- (650) 888-1756
- Employees
- 6
- Industry
- Biotech/Healthcare
Recent News & Media
AusperBio raises $50M to advance AHB-137 for chronic hepatitis B
- Jun 5, 2025
- liverdiseasenews.com
AusperBio Raises $50 Million in Series B+ to Advance Functional Cure for Chronic Hepatitis B
- May 28, 2025
- prnewswire.com
AHB-137 effective for chronic hepatitis B: Phase 2b clinical trial
- May 15, 2025
- liverdiseasenews.com
AusperBio Presents Interim Phase IIb AHB-137 Clinical Data in a Late-Breaking Abstract at EASL™ Congress 2025
- May 7, 2025
- prnewswire.com
Dosing complete in Phase 2b trial of AHB-137 for hepatitis B
- Feb 13, 2025
- liverdiseasenews.com
AusperBio Reaches Key Milestone with Dosing Completion and Study Unblinding in Ongoing AHB-137 Phase IIb Trial
- Feb 11, 2025
- prnewswire.com
Company Leadership
Companies Similar to AusperBio
Analyze industry trends and opportunities by examining competitors and companies comparable to AusperBio, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| Buffalo, NY | ||||
| 4 | Chandler, AZ | 2014 | ||
| 6 | Fort Worth, TX | |||
| 23 | Gainesville, FL | |||
| 4 | Marietta, GA |